Want to see SER full AI Analyst Report?
Serina Therapeutics (SER) Q2 2026 Earnings Report
SER Q2 2026 EPS Results
- Actual EPS
- -$0.55
- Consensus EPS
- -$0.47
- Beat/Miss
- Missed by -$0.08
- One Year Ago EPS
- -$0.66
SER Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
SER Upcoming Earnings
Serina Therapeutics's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
SER Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | -0.34- | -0.45 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.47-0.55 | -0.66 | 16.67% (+0.11) | |
| May 14, 2026 | 2026 (Q1) | -0.44-0.58 | -0.49 | -18.37% (-0.09) | |
| Mar 25, 2026 | 2025 (Q4) | -0.50-0.31 | -1.13 | 72.57% (+0.82) | |
| Nov 13, 2025 | 2025 (Q3) | -0.53-0.45 | 0.13 | -443.51% (-0.58) | |
| Aug 11, 2025 | 2025 (Q2) | -0.42-0.66 | 0.51 | -228.91% (-1.17) | |
| May 08, 2025 | 2025 (Q1) | -0.62-0.49 | -3.38 | 85.51% (+2.89) | |
| Mar 24, 2025 | 2024 (Q4) | 0.42-1.13 | -3.2 | 64.72% (+2.07) | |
| Nov 12, 2024 | 2024 (Q3) | ―0.13 | -5 | 102.62% (+5.14) | |
| Aug 09, 2024 | 2024 (Q2) | ―0.51 | -2.47 | 120.70% (+2.99) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
